Skip to main content
SpringerLink
Log in

Terconazole (TERAZOL): risk of anaphylaxis and TEN

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lau C. TERAZOL 7 Vaginal Cream 0.4% (terconazole); TERAZOL 3 Dual-Pak - Vaginal Cream 0.8%/Vaginal Ovules 80 mg (terconazole) - Risk of Anaphylaxis and Toxic Epidermal Necrolysis - For Health Professionals. Internet Document : 9 Jun 2014. Available from: URL: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39911a-eng.php.

    Google Scholar 

  2. Lau C. TERAZOL 7 Vaginal Cream 0.4% (terconazole); TERAZOL 3 Dual-Pak - Vaginal Cream 0.8%/Vaginal Ovules 80 mg (terconazole) - Risk of Anaphylaxis and Toxic Epidermal Necrolysis - For the Public. Internet Document : 9 Jun 2014. Available from: URL: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39915a-eng.php.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Terconazole (TERAZOL): risk of anaphylaxis and TEN. Reactions Weekly 1507, 2 (2014). https://doi.org/10.1007/s40278-014-1522-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1522-1

Search

Navigation